1.
Nidal Karim Al-Rahal, Oula Abdullah Najim, Ahmed Shemran Alwataify, Israa Mustafa Almusawi, Ahmed Ibrahim Shukr, Yaser Shanyor Alsalman. Emicizumab Prophylaxis Every Four weeks among Hemophilia a with Inhibitors in Iraq, Multicenter Study. JRTDD [Internet]. 2022 Dec. 30 [cited 2024 Jul. 3];5(2s):477-82. Available from: https://jrtdd.com/index.php/journal/article/view/170